Growth Metrics

Sarepta Therapeutics (SRPT) Change in Acquisitions & Divestments (2016 - 2025)

Sarepta Therapeutics has reported Change in Acquisitions & Divestments over the past 12 years, most recently at $99.9 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 89.65% year-over-year to $99.9 million; the TTM value through Dec 2025 reached $295.9 million, down 85.22%, while the annual FY2025 figure was $295.9 million, 85.22% down from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $99.9 million at Sarepta Therapeutics, up from $86.6 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $965.1 million in Q4 2024 and troughed at $30.0 million in Q3 2021.
  • A 5-year average of $308.6 million and a median of $279.7 million in 2024 define the central range for Change in Acquisitions & Divestments.
  • Biggest five-year swings in Change in Acquisitions & Divestments: surged 1231.9% in 2022 and later plummeted 91.47% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $30.0 million in 2021, then soared by 1388.34% to $446.5 million in 2022, then grew by 18.3% to $528.2 million in 2023, then skyrocketed by 82.71% to $965.1 million in 2024, then crashed by 89.65% to $99.9 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for SRPT at $99.9 million in Q4 2025, $86.6 million in Q3 2025, and $68.6 million in Q2 2025.